Brett Favre did not say he's planning another comeback, but he is talking about kids and football again.
In an interview with WDAM in Mississippi, Favre expressed the same sentiments he did last November when asked if he would ever allow his son to play football. Keep in mind, Favre doesn't have a son.
“It’s a violent sport, and for two reasons I don’t know if I’d let him play,” Favre said. “The pressures to, you know, live up to what your dad had done, but most importantly the damage that is done by playing. I don’t know if I would let him play.”
Favre also said it would be difficult for a son of his to live up to the legacy he built over a 20-year NFL career, which will undoubtedly land him in the Pro Football Hall of Fame.
Favre fears that multiple concussions during his career could have a negative impact on his future health. CBS Sports says Favre was sacked a remarkable 525 times during his career.
Pro Football Talk's Mike Florio thinks Favre is straying outside his area of expertise.
It’s easy for someone without a son to say, “I wouldn’t let him play football.” The more accurate explanation for someone who has a son who wants to play football is, “I’m worried he’ll get hurt, in the same way I worry about something happening to him in anything else he does that could result in him getting hurt.”
For Favre, the concern has a second prong that traces back to his own ego. Favre seems to believe it would be impossible for his male child to be as good as him at football, so he wouldn’t want him to be subjected to undue pressure to live up to the awkwardly-pronounced family name. (Joe Montana may agree with that general sentiment; Archie Manning may not.)
With his future health fears in mind, Favre is endorsing a concussion treatment company called Prevacus. It launched a nasal spray that, according to the company, reduces secondary damage of a concussion.
Jacob Vanlandhigham, the inventor of Prevacus says "you can reduce the secondary damage that occurs after the concussion" by using their treatment.
Favre recently joined the Prevacus advisory board.